C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/219, 167/227
C07D 471/04 (2006.01) C07D 215/20 (2006.01) C07D 215/233 (2006.01) C07D 215/42 (2006.01) C07D 215/54 (2006.01) C07D 491/10 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 1307526
Abstract 7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydro- genated pyrido[2,3-g]quinazoline derivatives are D-2 dopamine agonists. 6-Oxo-1-substituted-octahydroquino- lines and 6-oxo-1-substituted-decahydroquinolines which are additionally substituted in the 3- or 4-position are intermediates useful in preparation of the dopamine agonists. Acetals of 4,6-dioxo-1-substituted-decahydro- quinoline 3-carboxylic acid esters enable synthesis of the foregoing compounds.
539290
Huser Diane L.
Schaus John M.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
Huser Diane L.
Schaus John M.
LandOfFree
Bcd tricyclic ergoline part-structure analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bcd tricyclic ergoline part-structure analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bcd tricyclic ergoline part-structure analogues will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1220612